↓ Skip to main content

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

Overview of attention for article published in Journal of Clinical Oncology, January 2001
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
patent
15 patents
wikipedia
2 Wikipedia pages
guideline
4 clinical guideline sources

Readers on

mendeley
128 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.
Published in
Journal of Clinical Oncology, January 2001
DOI 10.1200/jco.2001.19.2.376
Pubmed ID
Authors

Elise Olsen, Madeleine Duvic, Arthur Frankel, Youn Kim, Ann Martin, Eric Vonderheid, Brian Jegasothy, Gary Wood, Michael Gordon, Peter Heald, Allan Oseroff, Lauren Pinter-Brown, Glen Bowen, Timothy Kuzel, David Fivenson, Francine Foss, Michael Glode, Arturo Molina, Elizabeth Knobler, Stanford Stewart, Kevin Cooper, Seth Stevens, Fiona Craig, James Reuben, Patricia Bacha, Jean Nichols

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 <1%
Poland 1 <1%
United Kingdom 1 <1%
Unknown 125 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 34 27%
Student > Bachelor 12 9%
Student > Master 12 9%
Other 11 9%
Student > Ph. D. Student 11 9%
Other 19 15%
Unknown 29 23%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 36 28%
Biochemistry, Genetics and Molecular Biology 16 13%
Agricultural and Biological Sciences 13 10%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Nursing and Health Professions 5 4%
Other 19 15%
Unknown 33 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2026.
All research outputs
#1,753,443
of 34,601,305 outputs
Outputs from Journal of Clinical Oncology
#4,965
of 32,791 outputs
Outputs of similar age
#2,730
of 176,788 outputs
Outputs of similar age from Journal of Clinical Oncology
#10
of 155 outputs
Altmetric has tracked 34,601,305 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,791 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,788 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 155 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.